Vanarix has developed a new generation of cell therapy to produce high-quality hyaline cartilage mini-grafts, named Cartibeads, which resemble native tissue. Cartibeads are bio-engineered from allogeneic chondrocytes and release their own hyaline matrix.
When implanted during minimally invasive arthroscopic surgery, Cartibeads can completely self-integrate into cartilage lesions and thus regenerate the tissue. Cartibeads are designed for the treatment of cartilage defects in traumatic and osteoarthritic joints.
Following successful first clinical trials, Biopôle-based Vanarix has raised CHF 4 million from new private investors. This funding will finance the upcoming clinical trial and support the implementation of automated manufacturing processes for Cartibeads, making this treatment accessible to a larger patient population. Vannary Tieng, PhD, MBAAlessandra de PicciottoVanarixBiopôle Lausannehttps://lnkd.in/gRYqmgTv
Proud to have Cartibeads treatments cited by AGEFI, Nouvelle Agence Économique et Financière . Thanks Sophie Marenne .
A clinical study with the new geneation of Cartibeads is currently underway at HUG - Hôpitaux Universitaires de Genève , Ente Ospedaliero Cantonale (EOC), Universitätsklinik Balgrist, Hirslanden Genève with the following investigators Philippe Tscholl Menetrey Jacques Sandro Fucentese @Marco Delcogliano and Luca Deabate
𝐊𝐞𝐧𝐳𝐨'𝐬 𝐟𝐢𝐫𝐬𝐭 𝐣𝐮𝐦𝐩 𝟔 𝐦𝐨𝐧𝐭𝐡𝐬 𝐚𝐟𝐭𝐞𝐫 𝐂𝐚𝐫𝐭𝐢𝐛𝐞𝐚𝐝𝐬 𝐭𝐫𝐚𝐧𝐬𝐩𝐥𝐚𝐧𝐭𝐚𝐭𝐢𝐨𝐧! 😍 🐎 💪
Kenzo a 4-year-old jumper suffering from a metacarpophalangeal lesion due to osteochondritis dissecans received Cartibeads produced from cartilage cells (chondrocytes) extracted and cultured from an 8-year-old adult donor horse.
Many thanks to Prof Olivier Lepage, 🙏 VetAgro Sup, Marcy l'Etoile, France, for this transplantation in one of the most challenging joint locations in horses: Our Cartibeads can support the weight of a horse weighing over 500 kg!
#cartilage , #regenerativemedicine , #orthopaedics , #stemcells , #veterinary , #osteoarthritis#cartilageregenerationBiopôle Lausanne